04 June 2021 : Original article
Coronavirus Disease 2019 and Kidney Transplantation in Saudi Arabia: Outcomes and Future Opportunities
Ali Alshaqaq1ABCDEF*, Abdulnaser Al Abadi1ACF, Abdulrahman Altheaby2ABF, Mohammed A. Bukhari3ABF, Basil Alnasrallah
1AB, Alaa Alamoudi4AB, Ziad Arabi2A, Fayez Alhejaili2B, Khalid Bin Saad2A, Ahmed Busbaih5B, Mohammed Abdelrahim Idris1AB, Sumayah Askandarani1AB, Meteb M. AlBugami1A, Fahad E. Alotaibe1E, Khaled Hamawi1E, Khalid Bel’eed Akkari1ACE
DOI: 10.12659/AOT.931832
Ann Transplant 2021; 26:e931832
Table 1 Baseline patient characteristics.
| Factors | Results (n=130)* |
|---|---|
| Male | 78 (60%) |
| Female | 52 (40%) |
| Age in years | 48.7±14.4 |
| Body mass index (BMI) | 29.8±6.9 |
| A | 36 (27.6%) |
| AB | 6 (4.6%) |
| B | 29 (22.3%) |
| O | 59 (45.3%) |
| Deceased donor | 26 (20%) |
| Living | 104 (80%) |
| Diabetes | 40 (30.8%) |
| Glomerulonephritis | 24 (18.5%) |
| Hypertension | 14 (10.8%) |
| Others | 52 (40%) |
| Diabetes | 58 (44.6%) |
| Hypertension | 103 (79.2%) |
| Ischemic heart disease | 22 (16.9%) |
| Smoking | 37 (28.5%) |
| Other | 65 (50%) |
| Steroid | 128 (98.5%) |
| Tacrolimus | 125 (96.2%) |
| Mycophenolate | 121 (93.1%) |
| Others | 6 (4.6%) |
| ≤1 year | 21 (16.2%) |
| >1 year | 109 (83.8%) |
| Family | 79 (60.8%) |
| Community | 29 (22.3%) |
| Unknown | 22 (16.9%) |
| * Results are expressed as mean±standard deviation, and number (percentage). | |